Edition:
United States

Profile: Knight Therapeutics Inc (GUD.TO)

GUD.TO on Toronto Stock Exchange

7.39CAD
24 May 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$7.39
Open
$7.40
Day's High
$7.42
Day's Low
$7.38
Volume
203,388
Avg. Vol
365,230
52-wk High
$8.81
52-wk Low
$7.10

Knight Therapeutics Inc is a Canada-based pharmaceutical company. The Company is engaged in developing, acquiring, in-licensing, out-licensing, marketing and distributing pharmaceutical products, consumer health products and medical devices in Canada and select international markets. It finances other life sciences companies in Canada and internationally. Its prescription pharmaceuticals and medical devices in various stages of development include Impavido, AzaSite, ATryn, Photofrin, ILUVIEN, TULSA-PRO, PROBUPHINE, Advaxis Family of Products, Ember Family of Products, NeurAxon Family of Products, Antibe Family of Products, Blood Factor Products and VEWS Vascular Early Warning System. In addition, the Company also has a portfolio of branded consumer health products, including Neuragen, Flat Tummy Tea, FOCUSFactor, FLEXISEQ, SEQuaderma, HandMD, UrgentRx, Laboratoire Dr. Renaud, Premiology and Pro-Derm.

Company Address

Knight Therapeutics Inc

3400 De Maisonneuve West
MONTREAL   QC   H3Z 3B8
P: +1514.4844483
F: +1514.4814116

Company Web Links